Trial Details

Not Recruiting
Basic Information
Clinical ID c2016
Identifier ChiCTR2400093919
Trial Title Multivariate Prediction, Identification Patterns, and Mechanisms of Biologic Therapy Response in Chinese Inflammatory Bowel Disease Patients
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Crohn's disease
Interventions Ustekinumab treatment group:Ustekinumab;Vedolizumab treatment group:Vedolizumab;
Participant Information
Sponsor Shenzhen Hospital of Southern Medical University
City -
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Observational study
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -